The Extracellular RNA Communication Consortium has published 800+ research articles since its inception in 2013. Articles in the category “Publications with Pathways” are listed here in reverse chronological order. Each article is tagged by category; you can browse different categories using the drop-down menu at the top of the page or by clicking on the tags of multi-category articles.
Cortez MA et al.
Role of miRNAs in immune responses and immunotherapy in cancer.
Genes Chromosomes Cancer (2019) 58:244-253.
Zhou S et al.
Chronic Platelet-derived Growth Factor Receptor signaling exerts control over initiation of protein translation in glioma.
Life Sci Alliance (2018) 1:e201800029.
Jun HJ et al.
A PDGFRalpha-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine.
Nat Commun (2018) 9:3116.
Gharpure KM et al.
FABP4 as a key determinant of metastatic potential of ovarian cancer.
Nat Commun (2018) 9:2923.
Koupenova M et al.
Circulating platelets as mediators of immunity, inflammation, and thrombosis.
Circ Res (2018) 122:337-351.
Hulsmans M et al.
Cardiac macrophages promote diastolic dysfunction.
J Exp Med (2018) 215:423-440.
Vannini I et al.
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.
Nat Commun (2017) 8:1801.
Bei Y et al.
Extracellular vesicles in cardiovascular theranostics.
Theranostics (2017) 7:4168-4182.
Mitamura T et al.
Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP).
Oncogene (2018) 37:722-731.
Shen P et al.
To Wnt or lose: The missing non-coding linc in colorectal cancer.
Int J Mol Sci (2017) 18:9.
Datta A et al.
Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells.
Cancer Lett (2017) 408:73-81.
Klingenberg M et al.
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.
J Hepatol (2017) 67:603-618.
Giza DE et al.
Cellular and viral microRNAs in sepsis: Mechanisms of action and clinical applications.
Cell Death Differ (2016) 23:1906-1918.
Ciccone M & Calin GA.
MicroRNAs in chronic lymphocytic leukemia: An old disease with new genetic insights.
MicroRNA (2016) 5:106-112.
Parasramka MA et al.
Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.
Pharmacol Ther (2016) 161:67-78.
Shields BB et al.
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression.
Mol Syst Biol (2015) 11:842.
Wong HK et al.
The Cancer Genome Atlas analysis predicts microRNA for targeting cancer growth and vascularization in glioblastoma.
Mol Ther (2015) 23:1234-47.
Li K et al.
Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-kappaB-driven inflammation and atherosclerosis.
Circ Res (2015) 117:e1-e11.
Miyake TM et al.
XPO1/CRM1 inhibition causes antitumor effects by mitochondrial accumulation of eIF5A.
Clin Cancer Res (2015) 21:3286-97.
Liu X et al.
miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling.
Cell Metab (2015) 21:584-95.
Gonzalez-Villasana V et al.
Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer.
Clin Cancer Res (2015) 21:2127-37.
Danielson KM & Das S.
Extracellular vesicles in heart disease: Excitement for the future?
Exosomes Microvesicles (2014) 2:1.
van den Beucken T et al.
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.
Nat Commun (2014) 5:5203.
Gangoda L et al.
Extracellular vesicles including exosomes are mediators of signal transduction: Are they protective or pathogenic?
Proteomics (2015) 15:260-71.
Leung CS et al.
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
Nat Commun (2014) 5:5092.
Han C et al.
The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression.
Cell Rep (2014) 8:1447-60.
Krzeszinski JY et al.
MiR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.
Nature (2014) 512:431-5.
Thomas MF, L’Etoile ND & Ansel KM.
Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways.
Trends Genet (2014) 30:298-307.
Yang L et al.
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer.
Mol Syst Biol (2014) 10:728.
Hu W et al.
Notch3 pathway alterations in ovarian cancer.
Cancer Res (2014) 74:3282-93.
Takahashi K et al.
Long noncoding RNA in liver diseases.
Hepatology (2014) 60:744-53.
